StockWatch
·

Senores Pharmaceuticals Ltd Q4 FY25 Results

SENORESQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue114.2110.9%
Total Income125.9816.5%
Expenditure105.3020.1%
PBT20.681.0%
Net Profit17.979.4%
OPM17.02%12.19pp
NPM14.26%0.93pp
EPS3.8124.4%
View full financials

Informational and educational content only. Not investment advice.